These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1321624)

  • 1. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP.
    Butt E; Nolte C; Schulz S; Beltman J; Beavo JA; Jastorff B; Walter U
    Biochem Pharmacol; 1992 Jun; 43(12):2591-600. PubMed ID: 1321624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Sp-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole- 3',5'-monophosphorothioate (Sp-5,6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells.
    Sandberg M; Butt E; Nolte C; Fischer L; Halbrügge M; Beltman J; Jahnsen T; Genieser HG; Jastorff B; Walter U
    Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):521-7. PubMed ID: 1659381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor.
    Butt E; Eigenthaler M; Genieser HG
    Eur J Pharmacol; 1994 Oct; 269(2):265-8. PubMed ID: 7851503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets.
    Geiger J; Nolte C; Butt E; Sage SO; Walter U
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):1031-5. PubMed ID: 1310537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS.
    Butt E; Pöhler D; Genieser HG; Huggins JP; Bucher B
    Br J Pharmacol; 1995 Dec; 116(8):3110-6. PubMed ID: 8719784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin.
    Draijer R; Vaandrager AB; Nolte C; de Jonge HR; Walter U; van Hinsbergh VW
    Circ Res; 1995 Nov; 77(5):897-905. PubMed ID: 7554143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases.
    Waldmann R; Nieberding M; Walter U
    Eur J Biochem; 1987 Sep; 167(3):441-8. PubMed ID: 2820726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors.
    Nolte C; Eigenthaler M; Horstrup K; Hönig-Liedl P; Walter U
    Biochem Pharmacol; 1994 Oct; 48(8):1569-75. PubMed ID: 7980622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro.
    Sirotkin AV; Makarevich AV; Genieser HG; Kotwica J; Hetényi L
    Exp Clin Endocrinol Diabetes; 2000; 108(3):214-9. PubMed ID: 10926319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
    Eigenthaler M; Nolte C; Halbrügge M; Walter U
    Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoaffinity labelling of cyclic GMP-inhibited phosphodiesterase (PDE III) in human and rat platelets and rat tissues: effects of phosphodiesterase inhibitors.
    Tang KM; Jang EK; Haslam RJ
    Eur J Pharmacol; 1994 Jun; 268(1):105-14. PubMed ID: 7925608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
    Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F
    Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets.
    Walter U; Eigenthaler M; Geiger J; Reinhard M
    Adv Exp Med Biol; 1993; 344():237-49. PubMed ID: 8209791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent inhibitory effects of cGMP-analogues on thrombin-induced platelet-derived microparticles formation, platelet aggregation, and P-selectin expression.
    Nygaard G; Herfindal L; Kopperud R; Aragay AM; Holmsen H; Døskeland SO; Kleppe R; Selheim F
    Biochem Biophys Res Commun; 2014 Jul; 449(3):357-63. PubMed ID: 24845383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activation by diacylglycerol or ionomycin is inhibited by nitroprusside.
    Doni MG; Deana R; Padoin E; Ruzzene M; Alexandre A
    Biochim Biophys Acta; 1991 Sep; 1094(3):323-9. PubMed ID: 1655043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the cGMP analog 8-PCPT-cGMP on agonist-induced increases in cytosolic ionized Ca2+ and on aggregation of human platelets.
    Menshikov MYu ; Ivanova K; Schaefer M; Drummer C; Gerzer R
    Eur J Pharmacol; 1993 May; 245(3):281-4. PubMed ID: 8392939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein.
    Russo I; Del Mese P; Doronzo G; De Salve A; Secchi M; Trovati M; Anfossi G
    Clin Chem; 2007 Jun; 53(6):1053-60. PubMed ID: 17463178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrovasodilators and cGMP inhibit human platelet activation.
    Doni MG; Alexandre A; Padoin E; Bertoncello S; Deana R
    Cardioscience; 1991 Sep; 2(3):161-5. PubMed ID: 1660321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cGMP inhibits IP3-induced Ca2+ release in intact rat megakaryocytes via cGMP- and cAMP-dependent protein kinases.
    Tertyshnikova S; Yan X; Fein A
    J Physiol; 1998 Oct; 512 ( Pt 1)(Pt 1):89-96. PubMed ID: 9729619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.